DONATE

IBEC organized the conference “The Future of Personalized Medicine” as part of the Complementary Plan for Biotechnology Applied to Health

Last Friday, the conference took place in Barcelona, bringing together over 100 attendees from the biomedical research field in Spain. Representatives from the Department of Health and Research and Universities of the Catalan Government were also present.

Samuel Sanchez receives the Constantes y Vitales Award

IBEC researcher Samuel Sánchez has been honored with the 2023 Constantes y Vitales Award in the “Young Talent in Biomedical Research” category for his work on designing self-propelled nanorobots capable of delivering drugs within the human body. This initiative, presented by LaSexta and AXA Foundation, aims to foster biomedical research in Spain and spotlight the contributions of its scientists.

Convergence of the three ISCIII Platforms to support R+D+i in Biomedicine and Health Sciences in Cadiz 

Last week, the ISCIII Platforms for R&D Support in Biomedicine and Health Sciences held their annual conference, organized by the Carlos III Health Institute (ISCIII). The event took place at the Cádiz Congress and Exhibition Center, bringing together nearly 400 participants interested in learning about the activities of the PNBB, SCReN, and ITEMAS platforms.  This … Read more

Bioengineering for future medicine in the 16th IBEC Symposium

IBEC’s 16th annual Symposium focused on ‘Bioengineering for Future and Precision Medicine,’ one of IBEC’s three key application areas. Approximately 300 people attended the event, including local and international researchers. It provided a multidisciplinary environment where experts from other institutions and the IBEC community had the opportunity to present their projects and exchange knowledge.

IBEC showcases its technological capabilities to foster new partnerships at BIOSPAIN

IBEC showcases its technological capabilities to foster new partnerships at BIOSPAIN. IBEC representatives actively participated in the BIOSPAIN conference, seizing the opportunity to highlight the institute’s advancements in science and technology. Over the three days of the event, they presented various aspects, ranging from basic research to the coordination of state plans and technology transfer conducted at IBEC. BIOSPAIN, a premier congress in Europe, brings together more than 850 innovative entities specializing in health, sustainable agri-food practices, and solutions against climate change.

Nanobots Therapeutics successfully closes a Pre-Seed funding round of €478,000

The start-up specializes in the development of biocompatible nanorobots capable of delivering drugs to difficult-to-treat tumors more efficiently and safely than current therapies. Nanobots Therapeutics is the third investment in the fifth edition of Banco Sabadell’s BStartup Health program, which received applications from 127 start-ups. The pre-seed funding round of the start-up Nanobots Therapeutics is … Read more

European funding for the treatment of Type 1 diabetes using 3D bioprinting

IBEC researcher Javier Ramón Azcón has been awarded an “ERC Proof of Concept Grant.” This prestigious funding is granted by the European Research Council to explore the commercial and societal potential of research projects conducted in European institutions. Ramón’s project, Uniink, is centered on the treatment of Type 1 diabetes using cell therapy and 3D bioprinting.

The ERC supports the “SpaceClones” project to understand the clonal evolution of tumors

Xavier Rovira Clavé, currently a researcher at Stanford University’s School of Medicine, has been awarded the “Starting Grant” from the European Research Council (ERC) to carry out his project “SpaceClones” at the Institute of Bioengineering of Catalonia (IBEC). This project aims to delve deeper into the understanding of tumor clonal evolution and its impact on … Read more

Samuel Sánchez Receives ERC Proof of Concept Grant to Target Mucinous Tumors with his Nanorobots

Samuel Sánchez has successfully secured an “ERC Proof of Concept” grant, provided by the European Research Council (ERC), to explore the application of his nanorobots in the treatment of mucus-secreting tumors. This prestigious grant enables researchers to assess the feasibility and potential for knowledge transfer of their research projects.